Adela Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 70

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $25.1M

  • Investors
  • 7

Adela General Information

Description

Developer of blood-based cancer detection technology designed to support early diagnosis and disease monitoring. The company offers a product that can detect and classify tumors using plasma cell-free DNA methylomes, enabling doctors in cancer detection, prenatal diagnostics, cardiology, and immune response monitoring.

Contact Information

Website
www.adelabio.com
Formerly Known As
DNAMx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 353 Hatch Drive
  • Foster City, CA 94404
  • United States
+1 (888)
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 353 Hatch Drive
  • Foster City, CA 94404
  • United States
+1 (888)

Adela Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adela Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 08-Jul-2025 $25.1M Completed Generating Revenue
4. Early Stage VC (Series A1) 27-Jul-2024 Completed Generating Revenue
3. Early Stage VC 11-Feb-2024 Completed Generating Revenue
2. Early Stage VC (Series A) 31-Mar-2021 $60M $60M Completed Generating Revenue
1. Seed Round 14-Jul-2020 $735K Cancelled Startup
To view Adela’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Adela Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of blood-based cancer detection technology designed to support early diagnosis and disease monitoring. The com
Decision/Risk Analysis
Foster City, CA
70 As of 2026

Madison, WI
 

Guangzhou, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adela Competitors (4)

One of Adela’s 4 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exact Sciences Formerly VC-backed Madison, WI
AnchorDx Formerly VC-backed Guangzhou, China
Nucleix Venture Capital-Backed Rehovot, Israel
Epigenomics Formerly VC-backed Heidelberg, Germany
To view Adela’s complete competitors history, request access »

Adela Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 8

    Pending

  • Expiring in next 12 mo

Adela Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025179073-A1 Methods and systems for tissue informed differentially methylated region analysis Pending 21-Feb-2024
EP-4695417-A1 Methods and systems for cell-free nucleic acid processing Pending 14-Apr-2023
US-20260125763-A1 Methods and systems for cell-free nucleic acid processing Pending 14-Apr-2023
WO-2024216205-A1 Methods and systems for cell-free nucleic acid processing Inactive 14-Apr-2023
WO-2024192294-A1 Methods and systems for generating sequencing libraries Inactive 15-Mar-2023 C12Q1/6869
To view Adela’s complete patent history, request access »

Adela Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adela Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
F-Prime Venture Capital Minority
Labcorp Holdings Corporation Minority
Labcorp Venture Fund Corporate Venture Capital Minority
Decheng Capital Venture Capital Minority
Deerfield Management Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Adela FAQs

  • When was Adela founded?

    Adela was founded in 2020.

  • Where is Adela headquartered?

    Adela is headquartered in Foster City, CA.

  • What is the size of Adela?

    Adela has 70 total employees.

  • What industry is Adela in?

    Adela’s primary industry is Decision/Risk Analysis.

  • Is Adela a private or public company?

    Adela is a Private company.

  • What is Adela’s current revenue?

    The current revenue for Adela is .

  • How much funding has Adela raised over time?

    Adela has raised $137M.

  • Who are Adela’s investors?

    F-Prime, Labcorp Holdings, Labcorp Venture Fund, Decheng Capital, and Deerfield Management are 5 of 7 investors who have invested in Adela.

  • Who are Adela’s competitors?

    Exact Sciences, AnchorDx, Nucleix, and Epigenomics are competitors of Adela.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process